Connect with us

Business

OrganiGram Holdings Inc (OTCMKTS:OGRMF) is In the Running After Recent Strategic Moves

Published

on

OrganiGram Holdings Inc (OTCMKTS:OGRMF) is on the outside looking in at CGC, ACB, and APHA as far as the elite group of global cannabis powers. But OGRMF might be high on the list of potential candidates to enter that class next. One factor that defines the top group is diversification, both in terms of geography and revenue streams, with strategic investments being a major part of that equation.

One move recently made by the company that you may have missed highlights how it may be making a fresh push in Q4 and Q1 2019 for more global diversification through strategic investments: the company announced a couple weeks ago that it has acquired 8,333 common shares of alpha-cannabis Pharma GmbH (a German cannabis name), representing a 25% stake, for aggregate proceeds of €1,625,000. This is exactly the type of deal that can push OGRMF into that top tier.

OrganiGram Holdings Inc (OTCMKTS:OGRMF) is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada.

OrganiGram is focused on producing the highest quality, condition-specific medical marijuana for patients in Canada. OGRMF’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations.

The company’s own portrayal of its market positioning runs as follows: “From the day we started back in 2013, it’s been about making lives better – for our clients, our people, and our community. We’re based in Moncton, New Brunswick, the heart of the Maritimes, but at OrganiGram Holdings we’re committed to improving the quality of life for Canadians across the country. For us, this means working with health-care providers and industry organizations, supporting research and education, and providing a safe, effective product.”

“To be effective in that last goal, we made a decision to produce organic cannabis. Growing certified organic medical cannabis isn’t easy, in fact, most licensed producers won’t take this on. It means more care, more testing, more rules… but in the end, it means a product that we feel delivers on our goals in the best way. And improving the quality of life for Canadians is not just about getting safe, quality product to them effectively. It’s about creating jobs, being good neighbors and contributing to our community.”

 

Movin’ On Up

OrganiGram Holdings Inc (OTCMKTS:OGRMF) managed to rope in revenues totaling $3.7M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 94.3%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($155.8M against $9.1M).

According to the release, Alpha-Cannabis’ Managing Directors Alexander Klomsdorff and newly appointed Dr. Volker Christoffel are pleased that the agreement with Organigram has now been formally finalized. ACG has been preparing the development and production of further cannabis based products for the swiftly growing German and European Markets following their recent product launch of “Cannabidiol alpha DAC”. “We look forward to a strong and fruitful partnership with our Canadian partners as we see significant potential in jointly materializing the medicinal benefits of Cannabinoids” ACG’s Managing Directors stated.

While this is a clear factor, it has been incorporated into a trading tape characterized by a pretty dominant offer, which hasn’t been the type of action OGRMF shareholders really want to see. In total, over the past five days, shares of the stock have dropped by roughly -4% on above average trading volume. All in all, not a particularly friendly tape, but one that may ultimately present some new opportunities.

“As we continue to build the framework of our international medical business, finding the right partners in the right markets has been a priority for our company,” stated Greg Engel, CEO at Organigram. “This relationship is a perfect example of two companies coming together towards a common goal, and we’re very excited to build our business in Germany through our partners at alpha-cannabis Pharma GmbH”

Business

General Cannabis Corp (OTCMKTS:CANN) Plans To Acquire A Denver Vertically Integrated Cultivator And Retailer

Published

on

General Cannabis Corp (OTCMKTS:CANN) is pleased to announce that it will soon make its latest acquisition. However, it first needs to make its entry into a non-binding term sheet. The target is to acquire a huge deal of assets belonging to one Colorado-based licensed recreational cannabis cultivator.

About the business deal

This Colorado business has been running some two indoor cultivation facilities. Asides from that, it has also been operating a retail cannabis dispensary which is situated in central Denver. This dispensary has risen to become one of the most trusted and successful dispensaries in Denver. Nevertheless, it prides itself in being the holder of a library of world-class cannabis genetics.

The Company has already signed the Colorado House Bill 1090 (“HB-1090”). Probably, this is the reason behind the latest activities the company has been undertaking. This law gives a leeway for the interested companies to acquire licensed cannabis companies in Colorado. The approval by the law might witness more companies follow suit in making these acquisitions.

Currently, the parties in charge are working on the various regulations in line with the implementation of the law. When finalized, the business giant reveals that it won’t hesitate in entering the binding transaction for the Business.

Focus into the future

General Cannabis has revealed its plan to purchase the Company’s common stock. These will include the company’s tangible and intangible assets. The business guru expects to pay 40% in terms of shares and sixty percent in form of cash. Focus will at some point shift to the number of common shares issued at closing. In this case, the determination will take into account the 30-day volume weighted average price.

The General Cannabis Chief Executive Officer and Executive Chairman Michael Feinsod expressed his excitement in the latest developments. He said that the acquisition of the third licensed Colorado cannabis operator was a major step forward for them. The official looks forward to the company expanding its business to central Denver. According to him, the planned move will show their dedication to an expansion strategy.

General Cannabis is set to also expand its customer base by a significant margin if all moves according to plan.

Continue Reading

Business

Leafbuyer Technologies Inc (OTCMKTS:LBUY) To Create A Mobile App With Blockchain Capabilities

Published

on

Leafbuyer Technologies Inc (OTCMKTS:LBUY) today spoke at length regarding the development of a new mobile application. The company spent several months in the creation of the all-encompassing application. One top official working with the business says that they will soon give a Press release regarding the latest move.

The application

The uniqueness of the application lies in how it manages to merge the various aspects of functionality. These include Leafbuyer’s search technology and the current deals. The business guru has also designed some blockchain wallet capabilities. The purpose is to ensure that the company’s loyal customers get the most from the move.

The CEO of Leafbuyer Kurt Rossner opines, “Leafbuyer provides multiple technology solutions to help businesses in the cannabis industry to attract and retain consumers. The integration of blockchain technology within the mobile application will boost transparency and provide accessible information regarding transactions and loyalty points.”

Leafbuyer says that the hosting of its wide range of products on multiple platforms will see it generate high profits. The tablets at participating dispensaries, the Leafbuyer app, and the Greenlight app are all remarkable platforms according to analysts.

This new application is all about centralizing the experience of the various consumers. Soon, the application will be distributed via the iOS App Store and the progressive web application (PWA).

Views about the future

The COO of Leafbuyer, Mark Breen, has spoken in relation to the much-awaited rollout. The official says that they look forward to seeing their consumers interact much more easily with clients. According to him, the ongoing efforts on the connection develop a good reputation for the company. Sooner or later, Leafbuyer will become very important for product company clients and dispensaries across the country.

Most of the consumers are looking forward to the completion of this app. They say that it will make it a lot easier for them to search for deals and businesses. The other services they will enjoy include the ordering of their favorite products as well as getting other items delivered. Those consumers that need to keep track of their loyalty points will do it more easily.

Continue Reading

Business

Cannabis Science Inc (OTCMKTS:CBIS) Confirms The Success Of Its Reorganization Activities

Published

on

Cannabis Science Inc (OTCMKTS:CBIS) has spoken in regards to its European business. The company outlines that its reorganization activities have been successful. For that reason, it is hopeful that it will be able to fulfill most of its customers’ requirements. The business giant also takes its stakeholders and business partners seriously and seeks to satisfy their needs effectively.

Company’s areas of focus

The reorganization is set to take efficiency of the CBIS’ European operations to the next level. This is according to one of the top executives in the company who believes the operation should be effective as well. The official says there is need to set in place the necessary infrastructure. This will make it possible for the business to manage its own supply chain logistics. The company also needs to focus on other areas such as revenue growth and new product development.

Cannabis Science has also settled on The Netherlands as the headquarters for its cultivation, extraction, and manufacturing activities. The company also wishes to let interested parties understand that it has already dissolved its former operations in Germany.

Mr. Dabney’s perspective

The Chief Executive Officer and also a co-founder Mr. Raymond C. Dabney outlines that they want to be more aggressive. They want to pay attention to major areas such as cultivation, product development activities and extraction. According to the top executive, the company wants to merge all its activities in Europe and let all of them run in a single organization.

Earlier, the initiatives were run through joint ventures. The parties here were CBIS Europe GmbH and Dupetit GmbH but will now run under CBIS Holding B.V. Dabney is confident that they will succeed in their efforts targeted at growing their business throughout the European market.

CBIS Holding B.V. is working on its business plans. Hopefully, it will be manufacturing and distributing the current CannaPOW® and Cannabia® beverage line. The other products it will be dealing in will be the hemp and cannabis-infused products.

Mr. Dabney has also confirmed that the company has also achieved other major business developments in the U.S. The recapitalization of CBIS preparations are currently underway and are running alongside the new important projects.

Continue Reading
Advertisement

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Trade


FEATURED STORIES

Business2 days ago

General Cannabis Corp (OTCMKTS:CANN) Plans To Acquire A Denver Vertically Integrated Cultivator And Retailer

Post Views: 187 General Cannabis Corp (OTCMKTS:CANN) is pleased to announce that it will soon make its latest acquisition. However,...

Business2 days ago

Leafbuyer Technologies Inc (OTCMKTS:LBUY) To Create A Mobile App With Blockchain Capabilities

Post Views: 391 Leafbuyer Technologies Inc (OTCMKTS:LBUY) today spoke at length regarding the development of a new mobile application. The...

Business3 days ago

Cannabis Science Inc (OTCMKTS:CBIS) Confirms The Success Of Its Reorganization Activities

Post Views: 280 Cannabis Science Inc (OTCMKTS:CBIS) has spoken in regards to its European business. The company outlines that its...

Business3 days ago

Agraflora Organics International Inc (OTCMKTS:AGFAF) And Eviana Strike A Beneficial Deal For Shareholders

Post Views: 219 Agraflora Organics International Inc (OTCMKTS:AGFAF) disclosed information regarding an offer it wants to make. If all goes...

BENEFITS OF CBD3 days ago

CBD and Endocrine Diseases

Post Views: 246 The endocrine system is a collection of glands all over the body that is responsible for the...

TRENDING4 days ago

CBD and Diabetes Treatment

Post Views: 378 CBD and Diabetes Treatment The hemp oil extracted from the cannabis plant is currently receiving good press...

Business4 days ago

ENDEXX ORD (OTCMKTS:EDXC) Targets 300 Stores Through Accelerated Growth Strategy

Post Views: 226 ENDEXX ORD (OTCMKTS:EDXC), also known as CBD Unlimited has announced the launch of an accelerated program that...

Business4 days ago

Medical Marijuana Inc (OTCMKTS:MJNA) Starts Producing Watermelon-Flavored CBD-Infused Gummies

Post Views: 191 Medical Marijuana Inc (OTCMKTS:MJNA) recently announced the launch of its watermelon-flavored CBD gummies, adding to its growing...

TRENDING4 days ago

CBD and Depression

Post Views: 381 Now that mental health is being given as much attention as physical health, it is becoming clearer...

Business5 days ago

Canopy Rivers Inc. (OTCMKTS:CNPOF) Receives Approval From Health Canada For Expansion Of Radicle Facility

Post Views: 256 Canopy Rivers Inc. (OTCMKTS:CNPOF) has announced that Radicle Medical Marijuana Inc. Its portfolio company has been approved...

Whats Hot

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play